Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a scientific article on the effect of ZEN-3694, Zenith’s novel …